NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
14.47
-0.10 (-0.65%)
At close: Feb 12, 2026, 4:00 PM EST
14.21
-0.25 (-1.76%)
After-hours: Feb 12, 2026, 7:42 PM EST
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $482.96 million as of February 12, 2026. Its market cap has increased by 14.51% in one year.
Market Cap
482.96M
Enterprise Value
494.13M
1-Year Change
14.51%
Ranking
Category
Stock Price
$14.47
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $482.96M, an increase of 22.80%. That is a compound annual growth rate of 4.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 484.96M | -5.70% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Varex Imaging | 569.27M |
| Cytek Biosciences | 560.05M |
| Perspective Therapeutics | 555.90M |
| Bioventus | 536.48M |
| Pacific Biosciences of California | 534.38M |
| Orthofix Medical | 534.20M |
| Standard BioTools | 459.56M |
| BrainsWay | 459.52M |